Clinical Research – Policy & Medicine

Unlocking the Fatty Liver Mistry: The Silent Threat of Fatty Liver Disease Unveiled

Oncology Unscripted with John Marshall, MD: Are You Overdosing Your Patients? Revisiting Dosing Practices

John Marshall Oncology Unscripted: CROs and the Rising Costs of Clinical Research — Do the Complexities of Clinical Trials Demand CRO Support?

Policy and Medicine Compliance Update May 2023 Issue Features: Regulatory Challenges in Diversity in Clinical Trials, Embracing Generative Artificial Intelligence, Novo Nordisk’s Trans-Atlantic Speech Woes, and The Sixth Circuit Tackles the Meaning of Remuneration in Kickback Cases

Could Simplified Clinical Trials Lead to More Diversity?

FDA Responds to Clinical Trials & Part 11 Compliance During COVID-19

Step Therapy: Is it Really More Cost Effective?

FDA Announces Study on Consumer and HCP Deception Perception

FDA Releases Guidance on IND Sponsors

FDA Issues Two Proposed Studies on Disclosures for Advertising